Wang Y, Yu J, Pei Y
Front Microbiol. 2024; 15:1505191.
PMID: 39703703
PMC: 11655498.
DOI: 10.3389/fmicb.2024.1505191.
SoRelle E, Reinoso-Vizcaino N, Horn G, Luftig M
Front Immunol. 2022; 13:1001145.
PMID: 36248899
PMC: 9554744.
DOI: 10.3389/fimmu.2022.1001145.
Qin N, Zhang Y, Xu L, Liu W, Luo B
Arch Virol. 2022; 167(10):1947-1959.
PMID: 35752684
DOI: 10.1007/s00705-022-05511-w.
Wen Y, Xu H, Han J, Jin R, Chen H
Front Cell Infect Microbiol. 2022; 12:852066.
PMID: 35281433
PMC: 8904896.
DOI: 10.3389/fcimb.2022.852066.
Yiu S, Guo R, Zerbe C, Weekes M, Gewurz B
Cell Rep. 2022; 38(10):110411.
PMID: 35263599
PMC: 8981113.
DOI: 10.1016/j.celrep.2022.110411.
Viruses in colorectal cancer.
Marongiu L, Allgayer H
Mol Oncol. 2021; 16(7):1423-1450.
PMID: 34514694
PMC: 8978519.
DOI: 10.1002/1878-0261.13100.
APOBECs and Herpesviruses.
Cheng A, Moraes S, Shaban N, Fanunza E, Bierle C, Southern P
Viruses. 2021; 13(3).
PMID: 33671095
PMC: 7998176.
DOI: 10.3390/v13030390.
Antisense Transcripts and Antisense Protein: A New Perspective on Human Immunodeficiency Virus Type 1.
Savoret J, Mesnard J, Gross A, Chazal N
Front Microbiol. 2021; 11:625941.
PMID: 33510738
PMC: 7835632.
DOI: 10.3389/fmicb.2020.625941.
Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Kerr J
Biomolecules. 2020; 10(11).
PMID: 33114612
PMC: 7692278.
DOI: 10.3390/biom10111484.
CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC.
Wang W, Zhang Y, Liu W, Zhang X, Xiao H, Zhao M
Theranostics. 2020; 10(25):11549-11561.
PMID: 33052232
PMC: 7545993.
DOI: 10.7150/thno.44251.
Host-Directed Antiviral Therapy.
Kumar N, Sharma S, Kumar R, Tripathi B, Barua S, Ly H
Clin Microbiol Rev. 2020; 33(3).
PMID: 32404434
PMC: 7227448.
DOI: 10.1128/CMR.00168-19.
Epigenetic lifestyle of Epstein-Barr virus.
Buschle A, Hammerschmidt W
Semin Immunopathol. 2020; 42(2):131-142.
PMID: 32232535
PMC: 7174264.
DOI: 10.1007/s00281-020-00792-2.
How Does Epstein-Barr Virus Contribute to Chronic Periodontitis?.
Imai K, Ogata Y
Int J Mol Sci. 2020; 21(6).
PMID: 32178406
PMC: 7139403.
DOI: 10.3390/ijms21061940.
Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
Siddiqi U, Vaidya A, Li X, Marcon E, Tsao S, Greenblatt J
J Virol. 2019; 93(20).
PMID: 31341047
PMC: 6798110.
DOI: 10.1128/JVI.00989-19.
Development of a novel inducer for EBV lytic therapy.
Tikhmyanova N, Paparoidamis N, Romero-Masters J, Feng X, Mohammed F, Reddy P
Bioorg Med Chem Lett. 2019; 29(16):2259-2264.
PMID: 31255485
PMC: 6690763.
DOI: 10.1016/j.bmcl.2019.06.034.
Control of viral infections by epigenetic-targeted therapy.
Nehme Z, Pasquereau S, Herbein G
Clin Epigenetics. 2019; 11(1):55.
PMID: 30917875
PMC: 6437953.
DOI: 10.1186/s13148-019-0654-9.
Ov2 is a modulator of OvHV-2 RTA mediated gene expression.
Dry I, Nightingale K, Ferguson J, Hopkins J, Dalziel R
Vet Res Commun. 2019; 43(2):91-97.
PMID: 30900113
PMC: 6525121.
DOI: 10.1007/s11259-019-09748-w.
Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.
Habib M, Buisson M, Lupo J, Agbalika F, Socie G, Germi R
Sci Rep. 2017; 7(1):10479.
PMID: 28874674
PMC: 5585268.
DOI: 10.1038/s41598-017-09798-7.
Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.
Nawandar D, Ohashi M, Djavadian R, Barlow E, Makielski K, Ali A
J Virol. 2017; 91(8).
PMID: 28179525
PMC: 5375685.
DOI: 10.1128/JVI.02438-16.
TRIM5α Promotes Ubiquitination of Rta from Epstein-Barr Virus to Attenuate Lytic Progression.
Huang H, Chen C, Wang W, Hsu S, Tsai H, Liu S
Front Microbiol. 2017; 7:2129.
PMID: 28105027
PMC: 5214253.
DOI: 10.3389/fmicb.2016.02129.
